AAAAAA

   
Results: 1-13 |
Results: 13
Aberrant dimerization of von Willebrand factor as the result of mutations in the carboxy-terminal region: identification of 3 mutations in members of3 different families with type 2A (phenotype IID) von Willebrand disease
Authors: Enayat, MS Guilliatt, AM Surdhar, GK Jenkins, PV Pasi, KJ Toh, CH Williams, MD Hill, FGH
Citation: Ms. Enayat et al., Aberrant dimerization of von Willebrand factor as the result of mutations in the carboxy-terminal region: identification of 3 mutations in members of3 different families with type 2A (phenotype IID) von Willebrand disease, BLOOD, 98(3), 2001, pp. 674-680
Human recombinant factor IX: safety and efficacy studies in hemophilia B patients previously treated with plasma-derived factor IX concentrates
Authors: Roth, DA Kessler, CM Pasi, KJ Rup, B Courter, SG Tubridy, KL
Citation: Da. Roth et al., Human recombinant factor IX: safety and efficacy studies in hemophilia B patients previously treated with plasma-derived factor IX concentrates, BLOOD, 98(13), 2001, pp. 3600-3606
Role of vector in activation of T cell subsets in immune responses againstthe secreted transgene product factor IX
Authors: Fields, PA Kowalczyk, DW Arruda, VR Armstrong, E McCleland, ML Hagstrom, JN Pasi, KJ Ertl, HCJ Herzog, RW High, KA
Citation: Pa. Fields et al., Role of vector in activation of T cell subsets in immune responses againstthe secreted transgene product factor IX, MOL THER, 1(3), 2000, pp. 225-235
Molecular analysis of the genotype-phenotype relationship in factor X deficiency
Authors: Millar, DS Elliston, L Deex, P Krawczak, M Wacey, AI Reynaud, J Nieuwenhuis, HK Bolton-Maggs, P Mannucci, PM Reverter, JC Cachia, P Pasi, KJ Layton, DM Cooper, DN
Citation: Ds. Millar et al., Molecular analysis of the genotype-phenotype relationship in factor X deficiency, HUM GENET, 106(2), 2000, pp. 249-257
Identification of type 2 von Willebrand disease in previously diagnosed type 1 patients. a reappraisal using phenotypes, genotypes and molecular modelling
Authors: Nitu-Whalley, IC Riddell, A Lee, CA Pasi, KJ Owens, D Enayat, MS Perkins, SJ Jenkins, PV
Citation: Ic. Nitu-whalley et al., Identification of type 2 von Willebrand disease in previously diagnosed type 1 patients. a reappraisal using phenotypes, genotypes and molecular modelling, THROMB HAEM, 84(6), 2000, pp. 998-1004
Type 2M vWD resulting from a lysine deletion within a four lysine residue repeat in the A1 loop of von Willebrand factor
Authors: Hilbert, L Jenkins, PV Gaucher, C Meriane, E Collins, PW Pasi, KJ Mazurier, C
Citation: L. Hilbert et al., Type 2M vWD resulting from a lysine deletion within a four lysine residue repeat in the A1 loop of von Willebrand factor, THROMB HAEM, 84(2), 2000, pp. 188-194
A survey of patients with acquired haemophilia in a haemophilia centre over a 28-year period
Authors: Yee, TT Taher, A Pasi, KJ Lee, CA
Citation: Tt. Yee et al., A survey of patients with acquired haemophilia in a haemophilia centre over a 28-year period, CLIN LAB H, 22(5), 2000, pp. 275-278
The effects of the 32-bp CCR-5 deletion on HIV transmission and HIV disease progression in individuals with haemophilia
Authors: Pasi, KJ Sabin, CA Jenkins, PV Devereux, HL Ononye, C Lee, CA
Citation: Kj. Pasi et al., The effects of the 32-bp CCR-5 deletion on HIV transmission and HIV disease progression in individuals with haemophilia, BR J HAEM, 111(1), 2000, pp. 136-142
Type 1 von Willebrand disease - a clinical retrospective study of the diagnosis, the influence of the ABO blood group and the role of the bleeding history
Authors: Nitu-Whalley, IC Lee, CA Griffioen, A Jenkins, PV Pasi, KJ
Citation: Ic. Nitu-whalley et al., Type 1 von Willebrand disease - a clinical retrospective study of the diagnosis, the influence of the ABO blood group and the role of the bleeding history, BR J HAEM, 108(2), 2000, pp. 259-264
Thrombotic risk factors associated with transurethral prostatectomy
Authors: Bell, CRW Murdock, PJA Pasi, KJ Morgan, RJ
Citation: Crw. Bell et al., Thrombotic risk factors associated with transurethral prostatectomy, BJU INT, 83(9), 1999, pp. 984-989
Novel cationic lipidic peptide dendrimer vectors - In vitro gene delivery
Authors: Toth, I Sakthivel, T Wilderspin, AF Bayele, H O'Donnell, M Perry, DJ Pasi, KJ Lee, CA Florence, AT
Citation: I. Toth et al., Novel cationic lipidic peptide dendrimer vectors - In vitro gene delivery, STP PHARM S, 9(1), 1999, pp. 93-99
Factor VIII inhibitors in haemophiliacs: a single-centre experience over 34 years, 1964-97
Authors: Yee, TT Pasi, KJ Lee, CA
Citation: Tt. Yee et al., Factor VIII inhibitors in haemophiliacs: a single-centre experience over 34 years, 1964-97, BR J HAEM, 104(4), 1999, pp. 909-914
Hemostasis - Components and processes
Authors: Pasi, KJ
Citation: Kj. Pasi, Hemostasis - Components and processes, METH MOL M, 31, 1999, pp. 3-21
Risultati: 1-13 |